Patients who have nasopharyngeal cancer, which starts behind the nose, could be given more effective treatment in the future after Chinese University researchers unveiled the complete genetic sets of a common cancer in Hong Kong.
The university, which analysed 111 tumour specimens, also found mutation of four specific sets of genes activated a group of proteins, named NF-kappaB, that promoted the growth of cancer cells in 40 per cent of the samples.
“NF-kappaB could be a new target. We...
↧